Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹752 Cr₹2,186 Cr₹-1,560 Cr₹1,587 Cr₹-177 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?

The latest Net Cash Inflow / Outflow ratio of GLAND PHARMA is ₹752 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹752 Cr
Mar2025₹2,186 Cr
Mar2024₹-1,560 Cr
Mar2023₹1,587 Cr
Mar2022₹-177 Cr

How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹752 Cr
-65.59
Mar2025 ₹2,186 Cr
Positive
Mar2024 ₹-1,560 Cr
Negative
Mar2023 ₹1,587 Cr
Positive
Mar2022 ₹-177 Cr -

Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹52,102.1 Cr 2.7% 8.4% 66% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,963.0 Cr 0.7% -0.3% 3.2% Stock Analytics
DIVIS LABORATORIES ₹269,451.0 Cr 4% 8.9% 54.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,456.0 Cr 3.6% -0.5% 28.8% Stock Analytics
DR REDDYS LABORATORIES ₹113,664.0 Cr 2.5% 13.6% 9.4% Stock Analytics
CIPLA ₹113,246.0 Cr 3.2% 5% -11.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.7%

8.4%

66%

SENSEX

5.5%

7.5%

-8.7%


You may also like the below Video Courses